marijuana stocks news

Form 8-K for LEXARIA CORP.


20-Jan-2016

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing Lexaria test results on nitric oxide filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.Exhibit No. Description

99.1 News Release dated January 20, 2016


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

IMLFF Receives Exemption Status from Health Canada

InMed Receives Exemption Status from Health Canada   VANCOUVER, British Columbia, March…

Tetra Bio-Pharma (TBPMF) Enters into Agreement to Acquire Remaining 20% Interest in Phytopain Pharma Subsidiary

Tetra Bio-Pharma Enters into Agreement to Acquire Remaining 20% Interest in Phytopain…

 AgraFlora Organics International Inc. (AGRA) (PUFXF) Integrates Proprietary Manufacturing Processes for Cannabinoid-Infused Formulations

AgraFlora Organics Integrates Proprietary Manufacturing Processes for Cannabinoid-Infused Formulations at GMP-Certified Toronto…

Digipath, Inc. (DIGP) Enters Into Validation Agreement with CASPR Technologies

Digipath Enters Into Validation Agreement with CASPR Technologies to Determine Efficacy for…